Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: Dysbiosis is associated with various systemic disorders including irritable bowel syndrome (IBS). Fecal microbiota transplantation (FMT) might restore intestinal microbial balance. The study aimed to determine the safety and efficacy of FMT in IBS patients, as well as also positive predictors for FMT. METHODS: This was a single-arm, open-label study. Eligible patients were diagnosed based on Rome III Diagnostic Criteria. Fecal materials were administered to the patient via colonoscopy. The primary end point was a change in the Bristol stool form scale at 4 weeks after FMT. Recovery to types 3-4 was considered a clinical response. The secondary end point was a change in intestinal microbiota and psychological status using the Hamilton Rating Scale. RESULTS: Ten patients were enrolled. Six patients achieved a clinical response. The diversity of patients 4 weeks after FMT increased significantly compared with patients before FMT, and that of responding patients was significantly higher than non-responder patients. The abundance of Bifidobacterium in effective donors was significantly higher than in ineffective donors and patients. Psychological status of all patients was significantly improved after FMT. CONCLUSIONS: FMT for patients with IBS is safe, and relatively effective. Bifidobacterium-rich fecal donor may be a positive predictor for successful FMT. Key Summary: (1) Dysbiosis is associated with various gastrointestinal disorders including IBS. (2) FMT has potential to restore intestinal microbial balance. (3) We showed that FMT improved stool form and psychological status of IBS patients. (4) Bifidobacterium-rich donor efficiently induced symbiosis in IBS patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mizuno et al. [90] in open-label, non-randomized, single-center trials found that psychiatric status of IBS patients, assessed using the Hamilton Rating Scale for Depression (HAMD), was significantly improved at 1 month after FMT from healthy donors, but returned to the baseline level after 12 weeks.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [90]
In the citing paper
“Three of the four studies found a significant improvement in anxiety symptoms following FMT [44, 45, 48].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“Although Mizuno et al. found improvement in the anxiety scores as well, it was not significant [44].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Cited by
Items 101–200 of 410
Song, Z., Feng, S., Zhou, X., Song, Z., Li, J., & Li, P. (2023) · iMeta · doi:10.1002/imt2.128 · Cited by 53
Yang, C., Hu, T., Xue, X., Su, X., Zhang, X., Fan, Y., Shen, X., & Dong, X. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03123-1 · Cited by 63
“In a population study, Mizuno et al. found that the psychiatric state of patients with IBS was significantly relieved one month after healthy individuals’ gut microbiota transplantation [19].”
BackgroundTargeting the gut microbiota for the treatment of irritable bowel syndrome
Herndon, C. C., Wang, Y., & Lu, C. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12154 · Cited by 62
“Successful FMT treatment for IBS may depend on host-microbiome characteristics, as it has been shown that Bifidobacterium rich donors can more efficiently induce symbiosis in IBS patients.(94)”
BackgroundNaito, Y., Takagi, T., Inoüe, R., Kashiwagi, S., Mizushima, K., Tsuchiya, S., Itoh, Y., Okuda, K., Tsujimoto, Y., Adachi, A., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-26 · Cited by 61
De, R., Mukhopadhyay, A. K., & Dutta, S. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00371-8 · Cited by 61
Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols
Hamamah, S., Gheorghita, R. E., Lobiuc, A., Sîrbu, I. O., & Covașă, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1060581 · Cited by 60
Hamada, K., Isobe, J., Hattori, K., Hosonuma, M., Baba, Y., Murayama, M., Narikawa, Y., Toyoda, H., Funayama, E., Tajima, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164724 · Cited by 60
Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122815 · Cited by 60
Park, A.-M., Omura, S., Fujita, M., Sato, F., & Tsunoda, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12401 · Cited by 59
Wakita, Y., Shimomura, Y., Kitada, Y., Yamamoto, H., Ohashi, Y., & Matsumoto, M. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1311-8 · Cited by 59
Halkjær, S. I., Lo, B. Z. S., Cold, F., Christensen, A. H., Holster, S., König, J., Brummer, R. J., Aroniadis, O. C., Lahtinen, P., Holvoet, T., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i20.3185 · Cited by 58
Reddi, S., Senyshyn, L., Ebadi, M., Podlesny, D., Minot, S. S., Gooley, T. A., Kabage, A. J., Hill, G. R., Lee, S. J., Khoruts, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56375-y · Cited by 57
Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
Almeida, C., Oliveira, R., Baylina, P., Fernandes, R., Teixeira, F. G., & Barata, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112742 · Cited by 58
Li, X., Yin, J., Zhu, Y., Wang, X., Hu, X., Bao, W., Huang, Y., Chen, L., Chen, S., Yang, W., et al. (2018) · Nutrients · doi:10.3390/nu10101403 · Cited by 46
Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes
Hashimoto, Y., Hamaguchi, M., Kaji, A., Sakai, R., Osaka, T., Inoüe, R., Kashiwagi, S., Mizushima, K., Uchiyama, K., Takagi, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13293 · Cited by 55
Typing of the Gut Microbiota Community in Japanese Subjects
Takagi, T., Inoüe, R., Oshima, A., Sakazume, H., Ogawa, K., Tominaga, T., Mihara, Y., Sugaya, T., Mizushima, K., Uchiyama, K., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10030664 · Cited by 54
Shimizu, Y., Yamamura, R., Yokoi, Y., Ayabe, T., Ukawa, S., Nakamura, K., Okada, E., Imae, A., Nakagawa, T., Tamakoshi, A., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2190306 · Cited by 53
Impact of long-term dietary habits on the human gut resistome in the Dutch population
Stege, P. B., Hordijk, J., Shetty, S. A., Visser, M., Viveen, M. C., Rogers, M. R. C., Gijsbers, E. F., Dierikx, C. M., van der Plaats, R. Q. J., van Duijkeren, E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05817-4 · Cited by 53
Human microbiome restoration and safety
Daliri, E. B.-M., Tango, C. N., Lee, B. H., & Oh, D.-H. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.05.002 · Cited by 48
The Future of Microbiome‐Based Therapeutics in Clinical Applications
Sharma, A., Das, P., Buschmann, M. M., & Gilbert, J. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1677 · Cited by 53
Wilmes, L., Collins, J. M., O’Riordan, K. J., O’Mahony, S. M., Cryan, J. F., & Clarke, G. A. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14095 · Cited by 54
Iino, C., Shimoyama, T., Chinda, D., Arai, T., Chiba, D., Nakaji, S., & Fukuda, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00712 · Cited by 52
The Timing Effects of Soy Protein Intake on Mice Gut Microbiota
Tamura, K., Sasaki, H., Shiga, K., Miyakawa, H., & Shibata, S. (2019) · Nutrients · doi:10.3390/nu12010087 · Cited by 52
The Ambiguous Correlation of Blautia with Obesity: A Systematic Review
Chanda, W., Jiang, H., & Liu, S. (2024) · Microorganisms · doi:10.3390/microorganisms12091768 · Cited by 51
García-Gutiérrez, E., O’Mahony, A. K., dos Santos, R. S., Marroquí, L., & Cotter, P. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2401654 · Cited by 52
Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon
Kaji, I., Akiba, Y., Furuyama, T., Adelson, D. W., Iwamoto, K., Watanabe, M., Kuwahara, A., & Kaunitz, J. D. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13157 · Cited by 51
Mizuno, S., Ono, K., Mikami, Y., Naganuma, M., Fukuda, T., Minami, K., Masaoka, T., Terada, S., Yoshida, T., Saigusa, K., et al. (2020) · Intestinal Research · doi:10.5217/ir.2019.00084 · Cited by 51
Self-citationMetagenomics analysis reveals features unique to Indian distal gut microbiota
Kaur, K., Khatri, I., Akhtar, A., Subramanian, S., & Ramya, T. N. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231197 · Cited by 50
Reconstruction of the personal information from human genome reads in gut metagenome sequencing data
Tomofuji, Y., Sonehara, K., Kishikawa, T., Maeda, Y., Ogawa, K., Kawabata, S., Nii, T., Okuno, T., Oguro-Igashira, E., Kinoshita, M., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01381-3 · Cited by 50
Yoshikata, R., Yamaguchi, M., Mase, Y., Tatsuyuki, A., Myint, K. Z. Y., & Ohta, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270242 · Cited by 49
Metagenomic analysis of gut microbial communities from a Central Asian population
Kushugulova, A., Forslund, S. K., Costea, P. I., Kozhakhmetov, S., Khassenbekova, Z., Urazova, M., Nurgozhin, T., Zhumadilov, Z., Benberin, V., Driessen, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021682 · Cited by 47
Nakajima, H., Takewaki, F., Hashimoto, Y., Kajiyama, S., Majima, S., Okada, H., Senmaru, T., Ushigome, E., Nakanishi, N., Hamaguchi, M., et al. (2020) · Life · doi:10.3390/life10090195 · Cited by 49
Nitrogen fixation and nifH diversity in human gut microbiota
Igai, K., Itakura, M., Nishijima, S., Tsurumaru, H., Suda, W., Tsutaya, T., Tomitsuka, E., Tadokoro, K., Baba, J., Odani, S., et al. (2016) · Scientific Reports · doi:10.1038/srep31942 · Cited by 47
Self-citationGlycosulfatase-Encoding Gene Cluster in Bifidobacterium breve UCC2003
Egan, M., Jiang, H., O'Connell Motherway, M., Oscarson, S., & van Sinderen, D. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.02022-16 · Cited by 46
Sun, W., Guo, Y., Zhang, S., Chen, Z., Wu, K., Liu, Q., Liu, K., Wen, L., Wei, Y., Wang, B., et al. (2018) · BioMed Research International · doi:10.1155/2018/8308671 · Cited by 44
“In addition, a single-arm open-label population-based study showed that FMT is a safe and relatively effective treatment for IBS, in which gastrointestinal dysmotility is involved [26].”
BackgroundJanati, A. I., Karp, I., Laprise, C., Sabri, H., & Emami, E. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01526-z · Cited by 47
Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis
Huang, H., Liu, Y., Zhi, W., Chen, C., Wang, C., Li, H., & Yang, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12018-x · Cited by 46
Mazzawi, T. R. E., Hausken, T., Hov, J. R., Valeur, J., Sangnes, D. A., El‐Salhy, M., Gilja, O. H., Hatlebakk, J. G., & Lied, G. A. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1624815 · Cited by 46
“The improvement in the stool form as evaluated by Bristol stool form scale following FMT has also been observed in a previous study [31].”
BackgroundMethodResultInfluentialElokil, A., Chen, W., Mahrose, K., El-Attrouny, M. M., Abouelezz, K., Ahmad, H. I., Liu, H., Elolimy, A. A., Mandouh, M. I., Abdelatty, A. M., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1022783 · Cited by 46
Tuz, A. A., Hasenberg, A., Hermann, D. M., Gunzer, M., & Singh, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1037330 · Cited by 45
“Interestingly, FMT composition enriched in Bifidobacterium produced a more favorable symbiosis after transplant and indicates the necessity of microbiota characterization in healthy donor FMT samples to select more favorable bacterial species (57).”
BackgroundLi, X., Yuan, Q., Huang, H., & Wang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695321 · Cited by 44
The Effect of White Rice and White Bread as Staple Foods on Gut Microbiota and Host Metabolism
Mano-Usui, F., Ikeda, K., Joo, E., Fujita, Y., Yamane, S., Harada, N., & Nobuya, I. (2018) · Nutrients · doi:10.3390/nu10091323 · Cited by 44
Shoji, F., Yamaguchi, M., Okamoto, M., Takamori, S., Yamazaki, K., Okamoto, T., & Maehara, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1040424 · Cited by 44
Chinda, D., Takada, T., Mikami, T., Shimizu, K., Oana, K., Arai, T., Akitaya, K., Sakuraba, H., Katto, M., Nagara, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07594-6 · Cited by 43
Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant
Ekekezie, C., Perler, B. K., Wexler, A., Duff, C., Lillis, C. J., & Kelly, C. R. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000499 · Cited by 43
Consideration of Gut Microbiome in Murine Models of Diseases
Zhang, C., Franklin, C. L., & Ericsson, A. C. (2021) · Microorganisms · doi:10.3390/microorganisms9051062 · Cited by 45
Watanabe, Y., Saito, Y., Hara, T., Tsukuda, N., Aiyama-Suzuki, Y., Tanigawa-Yahagi, K., Kurakawa, T., Moriyama-Ohara, K., Matsumoto, S., & Matsuki, T. (2021) · ISME Communications · doi:10.1038/s43705-021-00066-4 · Cited by 37
Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response
Otake, Y., Kayama, H., Kishikawa, T., Shinzaki, S., Tashiro, T., Amano, T., Tani, M., Yoshihara, T., Li, B., Tani, H., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211291 · Cited by 44
Sheffer, M. M., Uhl, G., Prost, S., Lueders, T., Urich, T., & Bengtsson, M. M. (2019) · Microorganisms · doi:10.3390/microorganisms8010008 · Cited by 42
Komiya, S., Naito, Y., Okada, H., Matsuo, Y., Hirota, K., Takagi, T., Mizushima, K., Inoüe, R., Abe, A., & Morimoto, Y. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-53 · Cited by 42
Chong, P. P., Chin, V. K., Looi, C. Y., Wong, W. F., Madhavan, P., & Yong, P. V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01870 · Cited by 42
Ross, F. C., Mayer, D. E., Gupta, A., Gill, C. I. R., Rio, D. D., Cryan, J. F., Lavelle, A., Ross, R. P., Stanton, C., & Mayer, E. A. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.018 · Cited by 41
Hirano, R., Sakanaka, M., Yoshimi, K., Sugimoto, N., Eguchi, S., Yamauchi, Y., Nara, M., Maeda, S., Ami, Y., Gotoh, A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1973835 · Cited by 43
Mizuno, S., Nanki, K., Matsuoka, K., Saigusa, K., Ono, K., Arai, M., Sugimoto, S., Kiyohara, H., Nakashima, M., Takeshita, K., et al. (2017) · Intestinal Research · doi:10.5217/ir.2017.15.1.68 · Cited by 40
Self-citationFecal transplantation: digestive and extradigestive clinical applications
Filip, M., Tzaneva, V., & Dumitrascu, D. L. (2018) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-946 · Cited by 40
“which improved the psychological status of IBS patients [26].”
BackgroundAbellón‐Ruiz, J., Jana, K., Silale, A., Frey, A. M., Baslé, A., Trost, M., Kleinekathöfer, U., & van den Berg, B. (2023) · Nature Communications · doi:10.1038/s41467-023-40427-2 · Cited by 39
Nagase, S., Ogai, K., Urai, T., Shibata, K., Matsubara, E., Mukai, K., Matsue, M., Mori, Y., Aoki, M., Arisandi, D., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00101 · Cited by 39
Elsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 39
Miura, N., & Okuda, S. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.015 · Cited by 38
Shimizu, Y., Nakamura, K., Kikuchi, M., Ukawa, S., Nakamura, K., Okada, E., Imae, A., Nakagawa, T., Yamamura, R., Tamakoshi, A., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00398-y · Cited by 38
Mucosa-associated gut microbiome in Japanese patients with functional constipation
Sugitani, Y., Inoüe, R., Inatomi, O., Nishida, A., Morishima, S., Imai, T., Kawahara, M., Naito, Y., & Andoh, A. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-93 · Cited by 37
Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes
Matsumoto, H., Shiotani, A., Katsumata, R., Fukushima, S., Handa, Y., Osawa, M., Murao, T., Handa, O., Umegaki, E., Inoüe, R., et al. (2020) · Digestion · doi:10.1159/000512167 · Cited by 37
Alterations in intestinal microbiota in ultramarathon runners
Sato, M., & Suzuki, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-10791-y · Cited by 37
Emerging Relationship between the Gut Microbiome and Prostate Cancer
Matsushita, M., Fujita, K., Hatano, K., Velasco, M. A. D., Tsujimura, A., Uemura, H., & Nonomura, N. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.220202 · Cited by 37
Jeon, S. R., Chai, J., Kim, C., & Lee, C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0627-8 · Cited by 36
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
Goldenberg, S. D., & Merrick, B. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120981526 · Cited by 36
Tomofuji, Y., Kishikawa, T., Maeda, Y., Ogawa, K., Otake-Kasamoto, Y., Kawabata, S., Nii, T., Okuno, T., Oguro-Igashira, E., Kinoshita, M., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100219 · Cited by 35
Average gut flora in healthy Japanese subjects stratified by age and body mass index
Yoshida, N., Watanabe, S., YAMASAKI, H., SAKUMA, H., Takeda, A., Yamashita, T., & Hirata, K. (2021) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2021-056 · Cited by 35
Yan, H., Vestergaard, G., Deng, L., Kot, W., Thymann, T., Brunse, A., & Nielsen, D. S. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00310-2 · Cited by 35
Kim, G.-H., Lee, K., & Shim, J. O. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02125-22 · Cited by 35
“(28) 10/10, adults Enzymatic lysis method using lysozyme (Sigma-Aldrich Co.”
MethodYamashita, M., Okubo, H., Kobuke, K., Ohno, H., Oki, K., Yoneda, M., Tanaka, J., & Hattori, N. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13048 · Cited by 35
Guccione, C., Patel, L., Tomofuji, Y., McDonald, D. L., Gonzalez, A., Sepich‐Poore, G. D., Sonehara, K., Zakeri, M., Chen, Y., Dilmore, A. H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56077-5 · Cited by 34
Medina, D. A., Li, T., Thomson, P., Artacho, A., Pérez‐Brocal, V., & Moyá, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02346 · Cited by 34
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome
Kumar, N. B., Hogue, S., Pow‐Sang, J. M., Poch, M. A., Manley, B. J., Li, R., Dhillon, J., Yu, A. C., & Byrd, D. A. (2022) · Cancers · doi:10.3390/cancers14163988 · Cited by 35
Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer’s disease
Nguyen, T. T. T., Fujimura, Y., Mimura, I., Fujii, Y., Nguyen, N. L., Arakawa, K., & Morita, H. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8297-7 · Cited by 34
Imoto, N., Morita, H., Amanuma, F., Maruyama, H., Watanabe, S., & Hashiguchi, N. (2018) · Journal of Perinatology · doi:10.1038/s41372-018-0172-1 · Cited by 33
Sasaki, H., Miyakawa, H., Watanabe, A., Nakayama, Y., Lyu, Y., Hama, K., & Shibata, S. (2019) · Nutrients · doi:10.3390/nu11112802 · Cited by 33
Lu, J. Y., Shi, L., Huang, D., Fan, W., Li, X., Zhu, L., Wei, J., & Fang, X. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19166 · Cited by 33
Rupp, S. K., & Stengel, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.844564 · Cited by 26
From dysbiosis to longevity: a narrative review into the gut microbiome’s impact on aging
Tseng, C., & Wu, C. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01179-x · Cited by 32
Cao, Y., Zhang, B., Wu, Y., Wang, Q., Wang, J., & Shen, F. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/5480961 · Cited by 33
Dale, H. F., & Lied, G. A. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2002-57 · Cited by 32
“In addition, the authors suggest that a donor holding a high fecal concentration of Bifidobacterium might be a positive predictor for successful FMT [62].”
BackgroundChen, Y., Lian, B., Li, P., Yao, S., & Hou, Z. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.947097 · Cited by 32
Ordering taxa in image convolution networks improves microbiome-based machine learning accuracy
Shtossel, O., Isakov, H., Turjeman, S., Koren, O., & Louzoun, Y. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2224474 · Cited by 33
Mouse Model of Anti-Obesity Effects of Blautia hansenii on Diet-Induced Obesity
Shibata, M., Ozato, N., TSUDA, H., Mori, K., Kinoshita, K., Katashima, M., Katsuragi, Y., Nakaji, S., & Maeda, H. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090452 · Cited by 32
Tohya, M., Sekizaki, T., & Miyoshi‐Akiyama, T. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy078 · Cited by 31
Kiguchi, Y., Nishijima, S., Kumar, N., Hattori, M., & Suda, W. (2021) · DNA Research · doi:10.1093/dnares/dsab019 · Cited by 31
Self-citationAssessment of metagenomic workflows using a newly constructed human gut microbiome mock community
Mori, H., Kato, T., Ozawa, H., Sakamoto, M., Murakami, T., Taylor, T. D., Toyoda, A., Ohkuma, M., Kurokawa, K., & Ohno, H. (2023) · DNA Research · doi:10.1093/dnares/dsad010 · Cited by 31
Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives
Cibulková, I., Řehořová, V., Hajer, J., & Duška, F. (2021) · Biomolecules · doi:10.3390/biom11101459 · Cited by 30
Ikubo, Y., Jujo, T., Hosomi, K., Park, J., Naito, A., Shoji, H., Misawa, T., Suda, R., Sekine, A., Sugiura, T., et al. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01932-0 · Cited by 30
Lee, A., Lee, J. Y., Jung, S.-W., Shin, S. Y., Ryu, H. S., Jang, S.-H., Kwon, J. G., & Kim, Y. S. (2023) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2023.028 · Cited by 30
Bartsch, M., Hahn, A., & Berkemeyer, S. (2023) · Metabolites · doi:10.3390/metabo13121182 · Cited by 30
ResistoMap—online visualization of human gut microbiota antibiotic resistome
Yarygin, K. S., Kovarsky, B. A., Bibikova, T. S., Melnikov, D., Tyakht, A., & Alexeev, D. G. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx134 · Cited by 30
The Need for Personalized Approaches to Microbiome Modulation
Jain, N. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00144 · Cited by 29
“Donor material rich in Bifidobacterium may stimulate the growth and expansion of undetectable strains in recipient microbiota to match the level of diversity observed in donor microbiota (33).”
BackgroundBile acid–gut microbiota crosstalk in irritable bowel syndrome
Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 30
“Of note, promising outcomes after treatment with FMT in IBS and some other disorders of gut–brain interaction have been demonstrated in several cases and clinical trials by now (Pinn et al. 2014; Tian et al. 2016; Mizuno et al. 2017; Johnsen et al. 2018).”
BackgroundMizoguchi, R., Karashima, S., Miyajima, Y., Ogura, K., Kometani, M., Aono, D., Konishi, S., Demura, M., Tsujiguchi, H., Hara, A., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01334-7 · Cited by 29
Effect of storage and DNA extraction method on 16S rRNA-profiled fecal microbiota in Japanese adults
Kawada, Y., Naito, Y., Andoh, A., Ozeki, M., & Inoüe, R. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-84 · Cited by 29
Schmidt, E. K. A., Raposo, P. J. F., Madsen, K. L., Fenrich, K. K., Kabarchuk, G., & Fouad, K. (2021) · Biology · doi:10.3390/biology10040254 · Cited by 28
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02408-5 · Cited by 28
“Even in the Japanese population, there is only one report of FMT for IBS [30]; in order to establish more effective FMT protocol in Japan, studies analyzing the microbiome changes in Japanese IBS patients are necessary.”
BackgroundResultImpact of a bathing tradition on shared gut microbes among Japanese families
Odamaki, T., Bottacini, F., Mitsuyama, E., Yoshida, K., Kato, K., Xiao, J., & van Sinderen, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-40938-3 · Cited by 28
Metadata
- Authors
- Mizuno, S., Masaoka, T., Naganuma, M., Kishimoto, T., Kitazawa, M., Kurokawa, S., Nakashima, M., Takeshita, K., Suda, W., Mimura, M., Hattori, M., & Kanai, T.
- Affiliations
- Keio University (JP)
- Waseda University (JP)
- ORCID
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 96
- Issue
- 1
- Pages
- 29-38
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- PMC
- PMC5637308
- OpenAlex
- W2657252452
- Cited by
- 395
- References
- 37
- Citations by year
- 2026: 7 · 2025: 28 · 2024: 34 · 2023: 52 · 2022: 76 · 2021: 46 · 2020: 45 · 2019: 41 · 2018: 38 · 2017: 19
- FWCI
- 41.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Digestion (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tokyo Medical and Dental University
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, irritable bowel syndrome, Bifidobacterium, donor selection, predictors of treatment response, gut dysbiosis, stool consistency, psychological state, Hamilton Depression Rating Scale, gut microbiota diversity
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adult, Bifidobacterium, Colonoscopy, Feces, Female, Humans, Intestines, Japan, Male, Middle Aged, Treatment Outcome, Living Donors, Irritable Bowel Syndrome, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.